Review of current status of targeted alpha therapy in cancer treatment

Targeted alpha therapy is an emerging alternative for palliative of a wide range tumor types. Data from preclinicaland clinical research demonstrates high potential the selective killing cells and minimal toxicity to surroundinghealthy tissues. This article summarizes developmental stages alpha-targeted benchtop commercialization.It discusses fundamental properties, production pathways, microdosimetry, possible targeting vectors. Proper coverage hasalso been given comparing it with other standard treatment procedures while exploring applications emitters.In end, like therapies, challenges faces its future impact on personalized medicine are also illustrated.